4 This occurred after a large-scale phase III randomized clinical trial (RCT) demonstrating increased rates of MASH resolution without fibrosis worsening (25.9% and 29.9%, respectively, versus 9.7% with placebo
Ask for written estimates showing medication, labs, and visit fees, plus any interest, late fees, or enrollment charges
It helps preserve muscle during weight loss, supports metabolism, and improves body composition so the weight you lose is more likely to be fat
Among people who have not taken a GLP-1 drug, about one in five (22%) say they would be interested in taking a GLP-1 drug to lose weight, including 7% who say they would be very interested. Women are more likely than men to say they would be at least somewhat interested in taking these drugs to lose weight (27% v